Robert G. Ferris

<i>In Vitro</i>Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor

Masanori Kobayashi, Tomokazu Yoshinaga, Takahiro Seki et al. · Antimicrobial Agents and Chemotherapy · 2010 · 371 citations · Full text

Neurovirology, Drug Discovery, Medicine +14

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of Action

Karen K. Biron, Richard J. Harvey, Stanley C. Chamberlain et al. · Antimicrobial Agents and Chemotherapy · 2002 · 361 citations · Full text

Viral Replication, Unique Mode, Molecular Biology +18

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey et al. · Nature · 2020 · 311 citations · Full text

Viral Persistence, Human Retrovirus, Immunodeficiencies +14

Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor

Karen R. Romines, George A. Freeman, Lee T. Schaller et al. · Journal of Medicinal Chemistry · 2005 · 167 citations

The Relative Activity of “Function Sparing” HIV-1 Entry Inhibitors on Viral Entry and CCR5 Internalization: Is Allosteric Functional Selectivity a Valuable Therapeutic Property?

Vanessa Muniz‐Medina, Stacey A. Jones, Jodi M. Maglich et al. · Molecular Pharmacology · 2008 · 77 citations